Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. April 2026 06:59 ET | Quelle: Phathom Pharmaceuticals

Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

~1.35 million total VOQUEZNA® prescriptions filled to date$58.3 million in Q1 net revenues, a 104% increase year-over-yearQ1 operating expenses of $61.8 million; non-GAAP operating expenses of $56.2...
30. April 2026 06:56 ET | Quelle: Research and Markets

Enteric Softgel Capsules Market Analysis Report 2026: $3.05 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Enteric Softgel Capsules Market Report 2026" has been added to ResearchAndMarkets.com's offering. The enteric softgel capsules market is...
30. April 2026 06:43 ET | Quelle: Research and Markets

Pharmaceutical Contract Development and Manufacturing Organization (CMO) Market Analysis Report 2026: $90.75+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development and Manufacturing Organization (CMO) Market Report 2026" has been added to ResearchAndMarkets.com's offering. ...
29. April 2026 16:01 ET | Quelle: Olema Oncology

Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors

Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors
29. April 2026 11:23 ET | Quelle: Research and Markets

Farm Animal Drugs Research Report 2026: $28.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Farm Animal Drugs Market Report 2026" has been added to ResearchAndMarkets.com's offering. The farm animal drugs market, having shown substantial...
29. April 2026 11:17 ET | Quelle: Research and Markets

Industrial Liquefied Natural Gas (LNG) Vaporizer Industry Report 2026: $1.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Industrial Liquefied Natural Gas (LNG) Vaporizer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The industrial...
29. April 2026 10:07 ET | Quelle: Research and Markets

Alcoholism Treatment Market Report 2026: Revenue to Reach $36.85 Billion in 2026, Growing by $2.27 Billion YoY

Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Alcoholism Treatment Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Alcoholism Treatment Market has...
29. April 2026 08:05 ET | Quelle: Candel Therapeutics

Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer

EVERSANA, a purpose-built, partner-led commercial organization, positions Candel for potential U.S. commercial launch following planned BLA submission in Q4 2026 NEEDHAM, Mass., April 29, 2026 ...
29. April 2026 07:00 ET | Quelle: X4 Pharmaceuticals

X4 Pharmaceuticals Announces European Commission Approval of XOLREMDI® (Mavorixafor), the First and Only Authorized Treatment for Patients with WHIM Syndrome in the European Union

- European Commercialization will be Led by X4 Pharmaceuticals’ Partner, Norgine - - Global, Pivotal Phase 3 Clinical Trial Ongoing to Evaluate Mavorixafor in Chronic Neutropenia - BOSTON, April ...
29. April 2026 07:00 ET | Quelle: EyePoint, Inc.

EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026

WATERTOWN, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients...

Vorherige Seite

Nächste Seite